v3.26.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2026
Jan. 31, 2026
Current assets:    
Cash and cash equivalents $ 115,562 $ 94,123
Restricted cash 2,811 2,805
Accounts receivable, net of allowance for credit losses of approximately $366 and $382 as of April 30, 2026 and January 31, 2026, respectively 77,313 154,811
Prepaid expenses and other current assets 38,176 34,876
Assets held for sale 53,148 81,279
Total current assets 287,010 367,894
Goodwill 287,650 287,650
Intangible assets, net 258,654 285,138
Other assets 19,697 22,436
Total assets 853,011 963,118
Current liabilities:    
Current maturities of long-term debt 6,404 6,404
Borrowings under accounts receivable facility 1,000 1,000
Accounts payable 9,056 15,170
Accrued compensation 22,336 37,280
Accrued expenses and other current liabilities 14,587 17,934
Deferred revenue 221,299 257,331
Liabilities associated with assets held for sale 39,229 41,822
Total current liabilities 313,911 376,941
Long-term debt 568,163 570,769
Deferred tax liabilities 34,712 33,849
Deferred revenue - non-current 1,117 1,117
Other long-term liabilities 7,923 10,669
Total long-term liabilities 611,915 616,404
Commitments and contingencies
Shareholders’ equity (deficit):    
Shareholders’ common stock - Class A common shares, $0.0001 par value per share: 18,750,000 shares authorized and 9,135,428 shares issued and 8,835,651 shares outstanding as of April 30, 2026, and 9,095,922 shares issued and 8,796,145 shares outstanding as of January 31, 2026 1 1
Additional paid-in capital 1,578,986 1,576,794
Accumulated (deficit) (1,626,324) (1,583,210)
Treasury stock, at cost - 299,777 shares as of April 30, 2026 and January 31, 2026 (10,891) (10,891)
Accumulated other comprehensive income (loss) (14,587) (12,921)
Total shareholders’ equity (deficit) (72,815) (30,227)
Total liabilities and shareholders’ equity (deficit) $ 853,011 $ 963,118